Aetna
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Aetna's revenues will grow 35.9% and EPS will grow 6.9%.
The average estimate for revenue is $12.00 billion. On the bottom line, the average EPS estimate is $1.40.
Revenue details
Last quarter, Aetna chalked up revenue of $9.51 billion. GAAP reported sales were 7.0% higher than the prior-year quarter's $8.92 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS details
Last quarter, non-GAAP EPS came in at $1.50. GAAP EPS of $1.48 for Q1 were 3.5% higher than the prior-year quarter's $1.43 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
Recent performance
For the preceding quarter, gross margin was 27.3%, 130 basis points worse than the prior-year quarter. Operating margin was 9.1%, 40 basis points worse than the prior-year quarter. Net margin was 5.1%, 60 basis points worse than the prior-year quarter.
Looking ahead
The full year's average estimate for revenue is $47.74 billion. The average EPS estimate is $5.82.
Investor sentiment
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 607 members out of 658 rating the stock outperform, and 51 members rating it underperform. Among 232 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 223 give Aetna a green thumbs-up, and nine give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Aetna is outperform, with an average price target of $55.97.
Is Aetna the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Aetna to My Watchlist.
